Have your own idea? Try our Stock Screener
UPDATED Jan 10, 2025
Explore the Global Biggest Losers Today. These Pharmaceuticals & Biotech Stocks have seen the largest drop in Market Cap from the previous trading day.
Company | Last Price | 1D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
KDNY | US$40.39 | 0.2% | 95.7% | US$2.9b | US$40.09 | PS495.8x | E22.6% | n/a | ||
A283100 | ₩664.00 | 0.2% | -71.0% | ₩4.3b | n/a | n/a | n/a | n/a | ||
USRM | US$0.0001 | 9,900.0% | 9,900.0% | US$66.2k | n/a | n/a | n/a | n/a | ||
GENO | SEK 24.65 | 0.4% | -51.6% | SEK 1.6b | SEK 39.00 | PE57.8x | E16.4% | n/a | ||
BMND.F | US$0.31 | 30.4% | n/a | US$23.8m | n/a | PE-33.8x | n/a | n/a | ||
1SKF401E | €35.00 | 12.9% | 16.7% | €56.7m | n/a | n/a | n/a | 137.7% | ||
6864 | NT$69.30 | 0.4% | 175.5% | NT$1.7b | n/a | n/a | n/a | n/a | ||
MDWD | US$16.72 | 4.4% | 32.2% | US$172.7m | US$29.00 | PS9.1x | E51.5% | n/a | ||
8432 | NT$61.20 | 0.3% | 18.6% | NT$2.3b | n/a | PE19.6x | n/a | 2.1% | ||
6467 | NT$49.35 | 0.3% | n/a | NT$2.5b | n/a | PB10.4x | n/a | n/a | ||
NGEN | CA$3.09 | 3.7% | 17.0% | CA$209.5m | CA$4.50 | PB23.7x | n/a | n/a | ||
UBX | US$1.79 | 34.6% | -3.8% | US$22.4m | US$7.00 | PB2.1x | E54.0% | n/a | ||
AGY | UK£0.074 | 2.2% | 194.4% | UK£351.5m | n/a | PS6.4x | E32.8% | n/a | ||
INDV | UK£9.72 | 0.7% | -21.0% | UK£1.2b | UK£13.12 | PS1.3x | E42.6% | 0% | ||
EXTX | NOK 3.48 | 7.4% | -71.0% | NOK 111.6m | n/a | PB6.4x | n/a | n/a | ||
TRMED | NOK 2.55 | 1.4% | 106.9% | NOK 597.7m | n/a | PB2.3x | n/a | n/a | ||
IMCR | US$30.40 | 0.6% | -57.5% | US$1.5b | US$62.38 | PS5.1x | E34.9% | n/a | ||
3164 | NT$19.80 | 0.5% | -18.4% | NT$1.7b | n/a | PE32.2x | n/a | 3.5% | ||
CLYM | US$2.00 | 7.0% | -26.5% | US$125.7m | US$10.00 | PB0.6x | E-29.6% | n/a | ||
6549 | NT$8.45 | 1.3% | -39.6% | NT$677.0m | n/a | PB11.8x | n/a | n/a | ||
RGEN | US$154.86 | 0.1% | -10.6% | US$8.7b | US$191.46 | PS13.7x | E42.2% | n/a | ||
ABVX | €6.47 | 2.2% | -35.3% | €409.8m | €29.94 | PS45.4x | E18.7% | n/a | ||
DTIL | US$5.70 | 26.7% | -55.8% | US$34.5m | US$33.60 | PE3.8x | E-31.6% | n/a | ||
6748 | NT$25.10 | 0.6% | -34.5% | NT$1.5b | n/a | n/a | n/a | n/a |